UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analog fiber-wireless downlink transmission of IFoF/mmWave over in-field deployed legacy PON infrastructure for 5G fronthauling

Journal of optical communications and networking, 2020-10, Vol.12 (10), p.D57-D65

2020

Volltextzugriff (PDF)

Plans and Technical Challenges for Telecom Italia FTTx Deployment

Fiber and integrated optics, 2008-07, Vol.27 (4), p.194-204

2008

Volltextzugriff (PDF)

Redundancy strategies for a high splitting optically amplified passive optical network

Journal of lightwave technology, 2001-02, Vol.19 (2), p.137-149

2001

Volltextzugriff (PDF)

Plans and Technical Challenges for Telecom Italia FTTx Deployment: Fiber Optics in Italy

Fiber and integrated optics, 2008, Vol.27 (4), p.194-204

2008

Volltextzugriff (PDF)

Experimental Demonstration of DSP-Assisted Electrical Duobinary Optimization for High Speed PON 25+ Gbps Using 10 Gbps APD Receiver

2018 European Conference on Optical Communication (ECOC), 2018, p.1-3

2018

Volltextzugriff (PDF)

Opportunities and Challenges When using Low Bandwidth Optics for Higher Capacity PON Systems

2020 Optical Fiber Communications Conference and Exhibition (OFC), 2020, p.1-3

2020

Volltextzugriff (PDF)

Burst-Mode Equalization Strategies in 25 Gbps US-PON using Duobinary and 10G-Class APD for 20-km in C-Band

2019 Optical Fiber Communications Conference and Exhibition (OFC), 2019, p.1-3

2019

Volltextzugriff (PDF)

Field demonstration of 25G-PON and XGS-PON burst-mode upstream coexistence

45th European Conference on Optical Communication (ECOC 2019), 2019, p.60

2019

Volltextzugriff (PDF)

Towards 50 Gb/s in High-Speed PON: Optimization of Modulation Formats Using Pre-Chirping

2018 20th International Conference on Transparent Optical Networks (ICTON), 2018, p.1-4

2018

Volltextzugriff (PDF)

Reliability of SuperPON systems

IEE conference publication, 1998, p.219-223

1998

Volltextzugriff (PDF)

Cost of ownership for different PON architectures

OFC '98. Optical Fiber Communication Conference and Exhibit. Technical Digest. Conference Edition. 1998 OSA Technical Digest Series Vol.2 (IEEE Cat. No.98CH36177), 1998, p.171-172

1998

Volltextzugriff (PDF)

Diabetes and COVID-19: The potential role of mTOR

Diabetes research and clinical practice, 2022-04, Vol.186, p.109813-109813, Article 109813

2022

Volltextzugriff (PDF)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection

HIV/AIDS (Auckland), 2023-01, Vol.15, p.23-28

2023

Volltextzugriff (PDF)

1613P Clinically advanced prostate cancer (CAPC) featuring BRCA2 loss: A comprehensive genomic profiling (CGP) study

Annals of oncology, 2024-09, Vol.35, p.S974-S974

2024

Volltextzugriff (PDF)

2024TiP NETOS: A personalized approach of neoadjuvant therapy, including INCB099280 monotherapy and bladder preservation, for muscle-invasive urothelial bladder carcinoma (MIBC) with ctDNA monitoring

Annals of oncology, 2024-09, Vol.35, p.S1165-S1166

2024

Volltextzugriff (PDF)

P214 - Impact of neoadjuvant chemo-immunotherapy on intra and post operative outcomes in patients with bladder cancer treated with radical cystectomy and pelvic lymph node dissection: Prospective surgical assessment from the NURE-Combo Trial

European urology, 2024-03, Vol.85, p.S296-S296

2024

Volltextzugriff (PDF)

Impact of neoadjuvant chemo-immunotherapy on intra and post operative outcomes in patients with bladder cancer treated with radical cystectomy and pelvic lymph node dissection: Prospective surgical assessment from the NURE-Combo Trial

European urology, 2024-03, Vol.85, p.S296

2024

Volltextzugriff (PDF)

A0875 - Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)

European urology, 2024-03, Vol.85, p.S1914-S1914

2024

Volltextzugriff (PDF)

Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)

European urology, 2024-03, Vol.85, p.S1914

2024

Volltextzugriff (PDF)

PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)

European urology, 2024-03, Vol.85, p.S1951

2024

Volltextzugriff (PDF)

A0901 - First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)

European urology, 2024-03, Vol.85, p.S1951-S1951

2024

Volltextzugriff (PDF)

695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma

Annals of oncology, 2021-09, Vol.32, p.S709-S709

2021

Volltextzugriff (PDF)

Integrated care prevents hospitalisations for exacerbations in COPD patients

The European respiratory journal, 2006-07, Vol.28 (1), p.123-130

2006

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(19)
Tagungsberichte
(7)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Analog fiber-wireless downlink transmission of IFoF/mmWave over in-field deployed legacy PON infrastructure for 5G fronthauling

Plans and Technical Challenges for Telecom Italia FTTx Deployment

Redundancy strategies for a high splitting optically amplified passive optical network

Plans and Technical Challenges for Telecom Italia FTTx Deployment: Fiber Optics in Italy

Experimental Demonstration of DSP-Assisted Electrical Duobinary Optimization for High Speed PON 25+ Gbps Using 10 Gbps APD Receiver

Opportunities and Challenges When using Low Bandwidth Optics for Higher Capacity PON Systems

Burst-Mode Equalization Strategies in 25 Gbps US-PON using Duobinary and 10G-Class APD for 20-km in C-Band

Field demonstration of 25G-PON and XGS-PON burst-mode upstream coexistence

Towards 50 Gb/s in High-Speed PON: Optimization of Modulation Formats Using Pre-Chirping

Reliability of SuperPON systems

Cost of ownership for different PON architectures

Diabetes and COVID-19: The potential role of mTOR

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection

1613P Clinically advanced prostate cancer (CAPC) featuring BRCA2 loss: A comprehensive genomic profiling (CGP) study

2024TiP NETOS: A personalized approach of neoadjuvant therapy, including INCB099280 monotherapy and bladder preservation, for muscle-invasive urothelial bladder carcinoma (MIBC) with ctDNA monitoring

P214 - Impact of neoadjuvant chemo-immunotherapy on intra and post operative outcomes in patients with bladder cancer treated with radical cystectomy and pelvic lymph node dissection: Prospective surgical assessment from the NURE-Combo Trial

Impact of neoadjuvant chemo-immunotherapy on intra and post operative outcomes in patients with bladder cancer treated with radical cystectomy and pelvic lymph node dissection: Prospective surgical assessment from the NURE-Combo Trial

A0875 - Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)

Comprehensive Genomic Profiling (CGP) of clinical T2-4N0M0 Muscle-Invasive Bladder Cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before Radical Cystectomy (RC)

PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT

PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE

First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)

A0901 - First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)

695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma

Integrated care prevents hospitalisations for exacerbations in COPD patients

Suchergebnisse filtern